MEGAN LENTZ: Open Payments
NPI 1902495138 · LITTLE RIVER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 42 payments from 15 companies in 2025. Trend: 2023 $429 · 2024 $713 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $215 |
| Novo Nordisk Inc | 8 | $176 |
| Phathom Pharmaceuticals, Inc. | 4 | $125 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Viatris Specialty LLC | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Exact Sciences Corporation | 2 | $35 |
| Amgen Inc. | 2 | $33 |
| Dexcom, Inc. | 1 | $30 |
Products named: VOQUEZNA, Wegovy, AIRSUPRA, FARXIGA, TRELEGY ELLIPTA, YUPELRI, LEQVIO, XIFAXAN.
Industry payments across SC — which companies pay providers there.
